CNR Institutional Research Information System

FUGGETTA, MARIA PIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.846
NA - Nord America 1.292
EU - Europa 1.167
SA - Sud America 357
AF - Africa 36
OC - Oceania 3
Totale 4.701
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.244
SG - Singapore 804
RU - Federazione Russa 661
CN - Cina 394
BR - Brasile 288
HK - Hong Kong 204
VN - Vietnam 197
IT - Italia 143
FR - Francia 115
DE - Germania 80
KR - Corea 69
JP - Giappone 55
NL - Olanda 39
GB - Regno Unito 34
IN - India 31
AR - Argentina 23
FI - Finlandia 20
MX - Messico 20
CA - Canada 16
EC - Ecuador 13
BD - Bangladesh 12
TR - Turchia 12
IL - Israele 11
IQ - Iraq 10
ZA - Sudafrica 10
AL - Albania 9
CO - Colombia 9
ES - Italia 9
MA - Marocco 9
PL - Polonia 9
UA - Ucraina 9
VE - Venezuela 9
ID - Indonesia 8
SE - Svezia 8
SA - Arabia Saudita 7
LT - Lituania 5
UZ - Uzbekistan 5
AT - Austria 4
IE - Irlanda 4
JM - Giamaica 4
MY - Malesia 4
PE - Perù 4
PK - Pakistan 4
PT - Portogallo 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
BO - Bolivia 3
CL - Cile 3
DZ - Algeria 3
EG - Egitto 3
PY - Paraguay 3
AO - Angola 2
AU - Australia 2
CH - Svizzera 2
ET - Etiopia 2
HU - Ungheria 2
KE - Kenya 2
PH - Filippine 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
UY - Uruguay 2
AM - Armenia 1
BE - Belgio 1
BS - Bahamas 1
CG - Congo 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CY - Cipro 1
GE - Georgia 1
GR - Grecia 1
HN - Honduras 1
IR - Iran 1
JE - Jersey 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
KY - Cayman, isole 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
MR - Mauritania 1
MT - Malta 1
MU - Mauritius 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
RO - Romania 1
SV - El Salvador 1
TL - Timor Orientale 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 4.701
Salva come PNG Salva come JPEG
Città #
Santa Clara 569
Singapore 453
Hong Kong 200
Hefei 134
Beijing 111
San Jose 90
Lauterbourg 83
Ashburn 76
Ho Chi Minh City 73
Seoul 69
Frankfurt am Main 64
Los Angeles 64
Rome 62
Tokyo 45
Hanoi 39
New York 28
São Paulo 27
Dallas 22
Guangzhou 16
Helsinki 15
Rio de Janeiro 14
Buffalo 13
Haiphong 13
Atlanta 12
Biên Hòa 11
Da Nang 10
Amsterdam 9
Brasília 9
Cavallino 9
Denver 9
Montreal 9
Naples 8
Stockholm 8
Boardman 7
Boston 7
Brooklyn 7
Minamishinagawa 7
Orem 7
Bengaluru 6
Campinas 6
Chennai 6
Düsseldorf 6
Houston 6
Istanbul 6
London 6
Porto Alegre 6
Baghdad 5
Chicago 5
Curitiba 5
Genoa 5
Johannesburg 5
Poplar 5
Portsmouth 5
Quito 5
Tirana 5
Toronto 5
Uberlândia 5
Warsaw 5
Ankara 4
Belo Horizonte 4
Buenos Aires 4
Council Bluffs 4
Dublin 4
Guayaquil 4
Jeddah 4
Kyiv 4
Lappeenranta 4
Lima 4
Marigliano 4
Milan 4
Mumbai 4
Munich 4
Newark 4
Phoenix 4
Santiago 4
Tashkent 4
Vienna 4
Baku 3
Bogotá 3
Bologna 3
Cape Town 3
Caracas 3
Cotia 3
Delhi 3
Elk Grove Village 3
Erbil 3
Florence 3
Franca 3
Gustavo Adolfo Madero 3
Hải Dương 3
Indaiatuba 3
Joinville 3
Kingston 3
Kuala Lumpur 3
Miami 3
Querétaro 3
Salvador 3
Santa Luzia 3
Wroclaw 3
Addis Ababa 2
Totale 2.661
Salva come PNG Salva come JPEG
Nome #
" In vitro effects of hyperthermia on natural cell-mediated cytotoxicity. 815
The Synergistic Combination of Curcumin and Polydatin Improves Temozolomide Efficacy on Glioblastoma Cells 146
Design and synthesis of a new Non-Covalent Caspase-3 Inhibitor with Neuroprotective Property 74
In vitro tumour cell growth inhibition: a comparative study between allosensitized cytotoxic T lymphocytes and lymphokine activated killer cells. 72
Influence of Polydatin on the Tumor Microenvironment In Vitro: Studies with a Colon Cancer Cell Model 71
Method for the extraction of pharmaceutically active product from spermatophyte plants, products thus obtained and their use in the medical field, in particular as substances with immunomodulating activity. 70
A possible interplay between HR-HPV and stemness in tumor development: An in vivo investigation of CD133 as a putative marker of cancer stem cell in HPV18 infected kb cell-line 68
"Apoptosis induction by LAK supernatant in a melanoma cell line: an electron microscopic study". 65
"Role of DNA repair enzymes in the antitumor and immunopharmacological effects of triazene compounds 65
Protective Effect of Limosilactobacillus fermentum ME-3 against the Increase in Paracellular Permeability Induced by Chemotherapy or Inflammatory Conditions in Caco-2 Cell Models 64
Design, synthesis and biological evaluation of 1,5-disubstituted aamino tetrazole derivatives as non-covalent inflammasome-caspase-1 complex inhibitors with potential application against immune and inflammatory disorders 64
A new synthetic spiroketal: Studies on antitumor activity on murine melanoma model in vivo and mechanism of action in vitro 64
A New synthetic spiroketal: Antitumor Activity On Murine Melanoma Model In Vivo and MOA In Vitro 62
SYNTHESIS AND ENANTIOMERIC SEPARATION OF A NOVEL SPIROKETAL DERIVATIVE: A POTENT HUMAN TELOMERASE INHIBITOR WITH HIGH IN VITRO ANTICANCER ACTIVITY 62
Anti-inflammatory Effect of Resveratrol and Polydatin by In Vitro IL-17 Modulation 59
Inflammatory Microenvironment and Adipogenic Differentiation in Obesity: The Inhibitory Effect of Theobromine in a Model of Human Obesity In Vitro 58
Anti-inflammatory Effect of Resveratrol and Polydatin by In Vitro IL-17 Modulation. 58
Caspasi, Miastenia Gravis e Distrofia Muscolare di duchenne 57
Potent Non-Covalent Inhibitors of Caspase-1 Targeting Neuroinflammation in Neurodegenerative Diseases 56
Antitumour activity of resveratrol on human melanoma cells: A possible mechanism related to its interaction with malignant cell telomerase. 56
Influence of low- dose beta interferon on natural killer activity in breast cancer patients subjected to chemotherapy. 55
INVITRO COMBINED EFFECTS OF HUMAN INTERFERONS AND INTERLEUKIN-2 ON NATURAL CELL-MEDIATED CYTOTOXICITY 55
Shedding light on the interaction of polydatin and resveratrol with G-quadruplex and duplex DNA: a biophysical, computational and biological approach. 55
Non-covalent inflammasome-caspase-1 complex inhibitors: New molecules targeting immune and inflammatory disorders including COVID-19 55
Synthesis and Enantiomeric Separation of a Novel Spiroketal Derivative: A Potent Human Telomerase Inhibitor with High in Vitro Anticancer Activity 54
Effect of 4-hydroxynonenal, a product of lipid peroxidation, on natural cell mediated cytotoxicity 52
Simvastatin inhibits the expression of stemness-related genes and the metastatic invasion of human cancer cells via destruction of the cytoskeleton. 50
Fatty acid synthase inhibitor orlistat impairs cell growth and down-regulates PD-L1 expression of a human T-cell leukemia line 49
Prophylactic Dermatologic Treatment of Afatinib-Induced Skin Toxicities in Patients with Metastatic Lung Cancer: A Pilot Study 47
Influence of fatty acid synthase inhibitor orlistat on the DNA repair enzyme O-6-methylguanine-DNA methyltransferase in human normal or malignant cells in vitro 46
2'-2'-difluorodeoxycytidine: in vitro effects on cell-mediated immune response. 45
Drug-induced xenogenization of tumors: A possible role in the immune control of malignant cell growth in the brain? 45
Polydatin displays antitumor activity against murine melanoma in vitro and in vivo 44
Drug-Induced Neoantigens: A New Horizon in Cancer Immunotherapy? 44
The immunomodulatory protein SV-IV protects serum-deprived cells against apoptosis but not against G0/G1 arrest: possible implications for the survival of implanting embryo 43
DIOXASPIROKETAL DERIVATIVES, PROCESS FOR THEIR PREPARATION AND USES THEREOF 43
IN VITRO ANTITUMOR ACTIVITY OF OLIVE OIL ANTIOXIDANTS TYROSOL AND HYDROXYTYROSOL AND THEIR METHYL CARBONATE DERIVATIVES 42
Effects of resveratrol on human immune cell function. 42
Attivazione delle risposte immunitarie mediante vaccini batterici 42
In vitro end points for the assessment of cellular immune response-modulating drugs 42
TARGETING NEUROINFLAMMATION THROUGH POTENT NON-COVALENT INHIBITORS OF CASPASE-1 41
In vitro antitumour activity of resveratrol in human melanoma cells sensitive or resistant to temozolomide. 40
Interferons antagonize gamma-ray-induced depression of natural immunity 40
Downregulation of proinflammatory cytokines in HTLV-1-infected T cells by Resveratrol 40
Tumor immunotherapy: drug-induced neoantigens (xenogenization) and immune checkpoint inhibitors. 40
In vitro effects of an immunostimulating bacterial lysate on human lymphocyte function. 40
In vitro infection of CD4(+) T lymphocytes with HTLV-I generates immortalized cell lines coexpressing lymphoid and myeloid cell markers 39
"Comparative studies on tumor cell growth inhibition induced by allosensitized cytotoxic lymphocytes and lymphokine activated killer cells 38
Antitumor activity of Piceid on human colon carcinoma and its effect on adhesion molecules of HUVEC cells 37
IN-VITRO TUMOR-CELL GROWTH-INHIBITION - A COMPARATIVE-STUDY BETWEEN ALLOSENSITIZED CYTOTOXIC T-LYMPHOCYTES AND LYMPHOKINE-ACTIVATED KILLER-CELLS 36
Effect of resveratrol on proliferation and telomerase activity of human colon cancer cells in vitro. 36
Effect of morphine on cell-mediated immune responses of human lymphocytes against allogeneic malignant cells. 36
Potent non-covalent inhibitors of Caspase-1 34
Anti-apoptotic seminal vesicle protein IV inhibits cell-mediated immunity. 34
SV-IV, a major protein secreted from rat seminal vesicle epithelium, promotes lymphocyte cytotoxic activity against the lymphoblastoid Raji cell line in human peripheral blood mononuclear cells 33
DNA repair enzymes and cytotoxic effects of temozolomide: comparative studies between tumor cells and normal cells of the immune system. 32
In vivo up-regulation of the molecular target in a pre-clinical model metastatic colorectal cancer vaccine. AACR-NCI-EORTC 32
La biologia della risposta immune 32
Identification of a new possibile molecular target for lung cancer: CSH-275 nonapeptide epitope 31
IMMUNOCHEMOTHERAPY OF ADVANCED COLORECTAL-CANCER WITH ALPHA-2A INTERFERON AND 5-FLUOROURACIL - IMMUNOPHARMACOLOGICAL STUDIES 31
Role of biological response modifiers in immunochemotherapy of solid tumors and retroviral-induced leukemia. 31
In vitro activity of 2'-2'-difluorodeoxycytidine (dFdc) on cellular immune response 31
In vitro and in vivo effects of SCV-07 in a murine B16 melanoma model. 30
Effect of hydrocortisone on human natural killer activity and its modulation by beta interferon 30
Individuazione di Nuovi Lead per la Cura di Patologie Neurodegenerative 30
La biologia della risposta immune 30
N-METHYLFORMAMIDE AFFECTS SPONTANEOUS METASTASES OF 3LL LINES AND INCREASES NATURAL-KILLER ACTIVITY OF TUMOR-BEARING MICE 29
Thymosin alfa up-regulates tumor antigen expression in colorectal cancer cells 29
The effect of O6-alkylguanine-DNA alkyltransferase and mismatch repair activities on the sensitivity of human melanoma cells 28
Identification of a new possible molecolar target for lung cancer: CSH-275 nonpeptide epitope. 28
A laboratory test based on determination of cytokine profiles: a promising assay to identify exposition to contact allergens and predict the clinical outcome in occupational allergic contact dermatitis 27
In vitro effect of hyperthermia on natural cell-mediated cytotoxicity. 27
Inhibitory effect on melanoma cell growth by supernatant of IL-2 activated MNC 27
Method for the extraction of pharmaceutically active product from spermatophyte plants, products thus obtained and their use in the medical field, in particular as substances with anti-tumoral activity. 27
In vivo effect of an immunostimulating bacterial lysate on human B lymphocytes. 27
Lymphonodes micrometastases detection by tumor associated antigens analysis 27
Evaluation of antigen specific recognition and cell mediated cytotoxicity by a modified lysispot assay in a rat colon carcinoma model. 26
Biological effects of resveratrol on human colo-carcinoma cell lines. 26
Effetto del resveratrolo sui livelli intracellulari di BCG in cellule mononucleate aderenti (AMNC) umane esposte in vitro al micobatterio 26
Drug-mediated increase of susceptibility of human lung cancer to NK or LAK effector cells 26
INCREASE OF NATURAL KILLER ACTIVITY OF MOUSE LYMPHOCYTES FOLLOWING IN-VITRO AND IN-VIVO TREATMENT WITH LITHIUM 26
NK Activity (NKA) in breast cancer patients subjected to adjuvant chemotherapy and low doses beta Interferon (LDIF). 25
Increase of NK activity of irradiated mononuclear cells induced by interferon in vitro. 25
METHOD FOR THE EXTRACTION OF PHARMACEUTICALLY ACTIVE PRODUCTS FROM SPERMATOPHYTE PLANTS, PRODUCTS THUS OBTAINED AND THEIR USE IN THE MEDICAL FIELD, IN PARTICULAR AS SUBSTANCES WITH IMMUNOMODULATING ACTIVITY 25
In vitro effects of resveratrol on human cell-mediated immunity. 25
Basi razionali per un'immunochemioterapia dei carcinomi dell'apparato digerente. 25
CHANGES OF IMMUNOLOGICAL PATTERNS OF HUMAN CANCER CELLS TREATED IN-VITRO WITH A TRIAZENE COMPOUND 24
Increased immunogenicity of murine limphoma cells following exposure to gamma rays "in vivo" 24
In vitro growth inhibition of HTLV-I+ MT-2 cell line, mediated by allosensitized cytotoxic T lymphocytes or lymphokine activated killer cells". 23
Natural-cell-mediated cytotoxicity: a micro assay suitable for clinical test. 23
Cell-mediated cytotoxicity and immunotherapy in cancer treatment 23
In vitro activity of 2'-2'-difluorodeoxycytidine (dFdc) on cellular immune response". 22
Antitumor effect of resveratrol on human melanoma cell lines. 22
International Symposium on Immunomodulation, Meeting Report 22
Combined effect of immunity and antitumor drugs against cancer. II. In vitro studies with cis-dicloro-diammineplatinum in a human leukemia system. 21
A miniaturized cell-mediated cytotoxicity assay with human effector mononuclear cells . 20
Interferon-Beta combined with interleukin-2 restores human natural cytotoxicity impaired in vitro by ionizing radiations. 20
Totale 4.735
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.112
article - articoli 8.153
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 181
Totale 21.446
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202456 0 0 0 0 0 0 0 0 8 0 45 3
2024/20251.669 12 13 110 60 484 115 18 101 42 61 360 293
2025/20263.010 110 212 226 341 423 110 348 115 800 180 59 86
Totale 4.735